Actimed Aims High With Cancer Cachexia Prospect
FDA Okays Late-Stage Program
Executive Summary
The UK firm has got the green light in the US to conduct two Phase IIb/III trials of its cancer cachexia candidate S-pindolol but a lot more money needs to be raised to complete them.